Louis Lehot and Eric Chow Assess How AI is Disrupting Dealmaking
September 8, 2023
Westlaw
Foley & Lardner LLP partners Louis Lehot and Eric Chow authored the Westlaw article, “How artificial intelligence is disrupting the dealmaking process,” offering insight onto how artificial intelligence and machine learning are effecting the mergers and acquisitions process and the issues that may arise with the use of these emerging technologies.
“AI is not yet at a place where the technology can replace all human interactions and procedures within a deal, and AI users should be cognizant of the issues and concerns presented above,” Lehot and Chow conclude. “But with proper safeguards in place, it can serve as a powerful ally in creating more informed and ultimately more successful deals.”
People
Related News
October 9, 2026
In the News
Jonathan Lasken Highlighted Across the Media for Arrival to Foley
Foley & Lardner LLP partner Jonathan Lasken is highlighted across the media for his recent arrival to the firm’s Washington D.C. office.
October 7, 2026
In the News
William Holtz Examines New FDA Approach to Clinical Trial Development
Foley & Lardner LLP of counsel William Holtz is quoted in the PharmaVoice article, “5 Key Facts About the FDA Expedited IND Pilot Program,” examining the FDA's new pilot program and its potential to accelerate clinical research.
October 5, 2026
In the News
Louis Lehot Analyzes U.S. IPO Market Trends and Outlook
Foley & Lardner LLP partner Louis Lehot is featured in the Daily Journal‘s Capital & Counsel newsletter offering insights on the current state of the U.S. IPO market and the factors influencing companies' routes to going public.